Data Driven Marketing

Global – October 28, 2026 -- Path2Response is offering custom digital audiences built on purchase records tied to 273 million individuals, with no model development or onboarding fees and payment only through clients' regular media buys.

Transaction data replaces interest-based inference in the targeting model

The company argues that the real divide in audience targeting is between fact and inference, not demographics. It says Facebook lookalike modeling builds largely on content engagement, while Google's targeting leans heavily on site visits and browsing context. Both read interest, which the company calls an inference by design.

Path2Response models start from the transaction itself. Records of past purchases, tied to core demographics, are submitted monthly by a growing network of retail and nonprofit contributors. Daily retail site-visitor signals and nonprofit gift-donation data are layered on top to capture real-time intent.

New York – September 22, 2026 -- PulsePoint has launched DTC Explorer, a self-service workspace that lets pharma marketers build and publish clinically-informed consumer audiences in hours instead of the longer timelines previously required for custom segment creation.

New tool cuts audience-building time by connecting clinical claims data to consumer targeting

DTC Explorer draws on PulsePoint's proprietary Bespoke Audiences, which are built from de-identified diagnosis, drug, and treatment claims. Users can filter by consumer demographics, clinical signals, prescribed drugs, insurance provider, geography, or NPI list, reviewing real-time aggregate device and consumer counts as they refine selections before publishing directly to the PulsePoint platform for activation.